Hong Kong Stock Alert | HEARTCARE-B (06609) Surges Nearly 7% in Late Trading as H1 Results Show Successful Turnaround to Profitability with Continued Enhancement of Integrated R&D-Production-Sales Ecosystem

Stock News
09/11

HEARTCARE-B (06609) surged nearly 7% in late trading. As of press time, the stock was up 6.8% to HK$64.4, with turnover reaching HK$25.0596 million.

On the news front, HeartCare Medical recently announced its interim results. In the first half of the year, the company achieved operating revenue of RMB 186 million, representing a 44.4% year-on-year increase. Net profit attributable to shareholders reached RMB 50.9 million, successfully turning from loss to profit and smoothly crossing the break-even point.

As noted in previous analysis, with hemorrhagic products beginning to contribute quantitatively in the first half and the ischemic product matrix continuing to iterate, the continuously improving "procedural closed loop" for access/hemostasis has become the main engine driving HeartCare Medical's revenue growth in the first half.

Furthermore, while accelerating efforts to "increase revenue and reduce costs," HeartCare Medical has been further enhancing its integrated R&D-production-sales innovation ecosystem in recent years, solidifying the foundation for the company's transition from "structural foundation" to "commercial realization."

As of now, the company has obtained NMPA approval for 32 device products, FDA approval for three device products, and CE marking for one product. The product pipeline extensively covers acute ischemic stroke and neurovascular stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and interventional access.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10